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Abstract
Background: S. Chiara hospital is the only neonatal intensive care unit (NICU) in the Province of
Trento (Italy). It serves a population of about 460000 people with about 5000 infants per year,
admitting the totality of the inborn and outborn VLBWI of the province. The aim of this work is to
compare mortality, morbidity and neonatal treatment of the very low birth weight infants (VLBWI)
of Trento area with those recorded in the Vermont Oxford Network (VON) during 2004.
Methods:  In this retrospective analysis, the rates of complications and related treatments
reported in VLBWI admitted in the S. Chiara NICU during the period 2000–2005 were compared
with those recorded in the VON in 2004. The analysis included both the total populations and
different weight groups.
Results: The frequency of inborn infants was significantly higher in Trento than in VON: 91% vs
84% (MH 8.56; p-value 0.003). The administration of prenatal steroids (82% vs 74%; MH 7.47 and
p-value 0.006) and caesarean section were significantly more frequent in the Trento area than in
VON. In Trento significantly more VLBWI with BW ≤ 1000 grams were given surfactant
prophylaxis compared with VON and significantly fewer VLBWI in every Trento weight group
developed RDS (MH 18.55; p-value 0.00001). Overall rates of complications (CLD, PDA, NEC,
IVH) were significantly lower than in the Vermont Oxford Network. In CLD and PDA the
differences were marked also in infants weighting less than 1000 grams. Overall rates of PNX, PVL,
severe grade of ROP and mortality were similar in the two populations. In Trento, significantly
more infants were discharged on human milk than in VON, in both the overall population and in
BW sub-groups.
Conclusion: On the basis of this analysis, a less aggressive therapeutic strategy based on perinatal
prevention in global management, such as that employed in Trento area, may be associated with an
improvement in clinical outcomes in very low birth weight infants.
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Background
Very low birth weight infants (VLBWI), i.e. those weighing
< 1500 grams, account for a very small percentage of all
live births but make a disproportionately large contribu-
tion to neonatal mortality and morbidity [1]. In 2002,
53.9% of infants who died in the USA were VLBWI [1]. In
Italy, the incidence of VLBWI is about one out of 100 live
births (5000 VLBWI per year) [1,2]. Moreover, mortality
rates in VLBWI are 100-fold higher than in other infants
[1]. Management of VLBWI at the intensive care level is
crucial for reducing mortality, morbidity and the risk of
long-term complications [3,4]. In the last 20 years, the
increased use of prenatal steroids and supplementary sur-
factant, and wider use of ventilation techniques, has pro-
vided major improvements in intensive care of VLBWI [5].
However, only a small number of studies involving large
populations of VLBWI are available to date. More such
studies may provide information on mortality and treat-
ment approaches, and form the basis for more effective
and less expensive therapeutic strategies [6].
VLBWI vary substantially in terms of mortality and
response to therapy, according to birth weight (BW) and
to gestational age (GA) [7]. Moreover, clinical outcomes
may vary between different areas as a result of specific
treatment strategies employed in individual intensive care
units, including emergency transport [6]. Therefore, data-
bases collecting information about VLBWI, classified on
the basis of GA and BW, may be important repositories for
clinical decision-making. The most notable example of
such a database is that of the Vermont Oxford Network
(VON) [8,9]. At its foundation in 1990, VON included 36
intensive care units. Currently, VON comprises more than
500 units worldwide, and records mortality, morbidity
and treatments for about 40000 VLBWI per year. At the
end of each year, the performance for each individual unit
is compared with the overall VON results. In Italy, only
five intensive care units were included in VON in 2004,
and thus little information on VLBWI morbidity and treat-
ments is available [1]. Therefore, therapeutic strategies
based on VON data rely upon the experiences of different
geographic areas [1]. Such choices may not be completely
suitable for individual local units.
S. Chiara hospital is the only neonatal intensive care unit
(NICU) in the Province of Trento (Italy). It serves a popu-
lation of about 460000 people with about 5000 infants
per year, of which one in 100 are VLBWI, admitting the
totality of the inborn and outborn VLBWI of the province.
Its provincial organization is based on the "in-uterus"
transport to S. Chiara and emergency transport from refer-
ral delivery points for only few cases every year. S. Chiara
is a 20-bed unit with eight beds dedicated to intensive
care, each providing assisted ventilation and monitoring
of vital parameters. NO treatment, radiography, echogra-
phy and haemogas-analysis devices, and infusion pumps
are also available. The working team includes 9 neonatol-
ogists and 25 nurses. Operative, surgical, orthopaedic and
neuropsychiatric units are present in the paediatric depart-
ment of S. Chiara. A specialised ophthalmologist is dedi-
cated to diagnosis of retinopathy of premature (ROP). In
the Trento area all the patients go directly home from S.
Chiara NICU. There is no other centre where they can be
transferred to. Even the follow up for the first 2 years of
life is made exclusively by S. Chiara NICU of Trento. The
S. Chiara neonatal intensive care unit provides emergency
transport for the entire Trento area.
Rather than a comparison among NICUs, this study wants
to be a comparison between two areas, the small Trento-
area and the big VON-area. The aim of this retrospective
analysis is to compare mortality, morbidity and treatment
of VLBWI in the S. Chiara intensive care unit during
2000–2005 with those recorded in VON during 2004. In
particular, this analysis focuses on infants weighing ≤
1000 grams.
Methods
In the Trento area, only 50 VLBWI are recorded each year
compared with about 40000 in VON. Therefore, consecu-
tive VLBWI data reported in S. Chiara during a six-year
period (2000–2005) were compared with a single year for
VON (2004).
Baseline data (inborn infants, use of prenatal steroids,
multiple births, incidence of small for gestational age
infants [SGA babies, defined for birth weight below the
10th percentile, in babies of the same gestational age [8]],
caesarean sections, congenital anomalies, need for intuba-
tion in delivery room) were collected for the two popula-
tions. The incidence of respiratory distress syndrome
(RDS), defined as radiologically confirmed clinical signs
of respiratory distress [5], and of pneumothorax were
evaluated, as well as the frequency of chronic lung disease
(CLD), defined as the need for oxygen supplementation at
28 days and 36 weeks [1]. In terms of respiratory compli-
cations, the frequency of surfactant administration (Curo-
surf®; Chiesi Farmaceutici, Parma, Italy [200 mg/kg
bolus]) was recorded. Surfactant was given as a prophylac-
tic measure in the delivery room to all babies with GA <
29 weeks. In Trento area the policy about ELBWI (22–24
weeks of GA) is based on the active care with resuscitation
since the 22nd week. In general the Trento policy for all the
VLBWI is based on the early prophylactic administration
of surfactant in Trento in delivery room or in the first
hours of life; this step is followed by the clinical evalua-
tion that permits to continue with a minimal handling or,
if strictly necessary, with high invasivity (catheters, antibi-
otics, ventilations, etc...). Furthermore, the need for nasal
continuous positive airway pressure (NCPAP) and con-Italian Journal of Pediatrics 2009, 35:5 http://www.ijponline.net/content/35/1/5
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ventional ventilation (Newport and Cub Bear ventilators;
Burke & Burke) was observed. Other complications
recorded included: patent ductus arteriosus (PDA), as
determined by echocardiography (treatment with
indomethacin [Liometacen®, Chiesi Farmaceutici, 0.20
mg/kg/day i.v. for three days, administered over 20 min-
utes] was also recorded); necrotising enterocolitis (NEC),
defined as gastrointestinal signs and symptoms associated
with specific radiological and operative evidence [5];
total, grade III and IV (Papile's classification) intraven-
tricular haemorhage (IVH), diagnosed with ultrasonogra-
phy [5]; and cystic periventricular leukomalacia (PVL),
defined on ultrasound as multiple small cysts located in
the external angles of the lateral ventricles, fronto-parietal
or occipital peri-ventricular white matter [5]. ROP was
scored according to international classification [5]. ROP
screening frequency and results, and the need for surgical
intervention for this condition were also evaluated. Over-
all mortality was calculated, as well as the total number of
discharged infants and those discharged on human milk.
The incidence of each parameter was calculated in both
the overall population and sub-groups defined by BW
(501–750 grams, 751–1000 grams, 1001–1250 grams,
1251–1500 grams). Incidences were compared using
odds ratios (OR) and the respective 95% confidence inter-
vals (95% CI). The differences between the two popula-
tions were calculated with the Mantel-Haenzel estimate
(MH).
Results
A total of 250 VLBWI in the Trento area and 38895 in
VON were evaluated. Baseline data for the two popula-
tions, and BW-defined sub-groups, are summarised in
Table 1 (Additional file 1).
The mean birth weight in each BW category is similar in
the two populations. VON in 2004 did not report the
mean gestational age.
Table 2 (Additional file 2) lists the prenatal data for the
two populations. The frequency of inborn infants was sig-
nificantly higher in Trento than in VON: 91% vs 84%
(MH 8.56; p-value 0.003). In addition, some treatments,
such as the administration of prenatal steroids (82% vs
74%; MH 7.47 and p-value 0.006) and caesarean section
were significantly more frequent in the Trento area than in
VON. The frequencies of congenital anomalies, multiple
births were similar between Trento and VON. SGA infants
were less frequent in Trento.
Table 3 (Additional file 3) lists the incidence of respiratory
complications and related treatments in the two popula-
tions. In Trento the overall need for intubation was signif-
icantly less frequent in the sub-group with BW 1251–
1500 grams, but significantly more VLBWI with BW ≤
1000 grams were given surfactant prophylaxis compared
with VON. Compared with VON, significantly fewer
VLBWI in every Trento weight group developed RDS, and
therefore needed specific treatment (MH 18.55; p-value
0.00001), with the use of conventional ventilation and
nasal CPAP (never before mechanical ventilation and
never with high flow nasal cannula) significantly less fre-
quent in Trento. Only in the sub-group with BW 501–750
grams the frequency was similar in the two populations.
Greater use of surfactant prophylaxis and lower incidence
of RDS in Trento compared with VON were particularly
evident in the 501–1000 grams group. The same trend
was found for CLD at 36 weeks: 5% vs 36% in VON (MH
102.5; p-value 0.00000). In Trento postnatal steroids for
CLD are not used. The overall frequency of pneumothorax
was similar in the two populations.
Table 4 (Additional file 4) summarises the incidence of
other complications and of indomethacin administration.
In Trento, PDA (14% vs 37%; MH 54.51; p-value
0.00000) and subsequent use of indomethacin (12% vs
34%; MH 55.65; p-value 0.00000) were significantly less
frequent than in VON. This difference was greatest in the
two lowest BW groups, as was also the case with respira-
tory complications. In Trento, NEC (2% vs 6%; MH 8.57;
p-value 0.003) was significantly less frequent than in
VON. Moreover, even if all the IVHs were significantly less
frequent in Trento than in VON, the analysis of IVH-grade
did not show any difference. There were no significant dif-
ferences in the incidence of PVL.
Table 5 (Additional file 5) lists the frequencies of other
parameters analysed, including mortality. Screening for
ROP was significantly more common in Trento than in
VON (83% vs 67%; MH 29.5; p-value 0.000001). The
overall incidence of ROP was significantly lower in the S.
Chiara intensive care unit, in all the BW sub-groups. No
significant difference was evident in the incidence of
severe grade of ROP.
Overall mortality was comparable in the two populations
(10% and 14% in Trento and VON, respectively). Further-
more, in Trento, significantly more infants were dis-
charged on human milk than in VON, in both the overall
population (MH 139.7; p-value 0.00000) and in BW sub-
groups [Figure 1].
Discussion
This analysis reports the complications and treatments in
the S. Chiara hospital (Trento, Italy) neonatal intensive
care unit during 2000–2005. As the only intensive care
centre in Trento (an area comprising 6200 km2), and serv-
ing the entire population (500000 inhabitants, with 5000
newborns per year), S. Chiara data might be an importantItalian Journal of Pediatrics 2009, 35:5 http://www.ijponline.net/content/35/1/5
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source of epidemiological information. Data recorded in
S. Chiara were compared with the entire VON database (S.
Chiara is part of this network), therefore comparing a
small area (2000–2005) with a global group, represented
by VON (2004). In this way, it is possible to critically eval-
uate therapeutic strategies used in S. Chiara, in a global
management of a perinatal area.
The two populations had similar rates of congenital
anomalies, SGA infants, and multiple births; some inter-
vention strategies were significantly more common in
Trento than in VON. For instance, caesarean section,
which is a common choice in Italy, especially in recent
years [10].
In Trento, the use of prenatal steroids and the use of sup-
plementary surfactant prophylaxis is significantly more
common than in VON. The surfactant strategy is based on
a multicentre retrospective European study that suggested
that prophylactic surfactant administered within 15 min-
utes of delivery is associated with a significantly greater
reduction in RDS than rescue therapy (administration
after 15 minutes of life) [11]. Moreover, a head-to-head
comparison of surfactant prophylaxis versus rescue ther-
apy confirmed the same finding, suggesting that prophy-
laxis is associated with a reduction in mortality [12].
The use of prenatal steroids with the greater use of sur-
factant prophylaxis may be associated with the lower inci-
dence of RDS reported in Trento. Effective management of
this condition could reduce the risk of CLD, as suggested
by the present analysis and by another study [13]. Sur-
factant prophylaxis, administered within the first few
minutes of birth in the delivery room, may also result in
fewer infants requiring assisted ventilation, thus reducing
invasive procedures without worsening clinical outcomes
[11]. The reduction in frequency of respiratory complica-
tions, as CLD, in Trento compared with VON is particu-
larly evident in the two lowest BW groups (501–750
grams and 751–1000 grams), which are characterised by a
particularly high risk. In these groups, surfactant prophy-
laxis was more common, further suggesting that this treat-
ment may be associated with important improvements in
clinical outcomes and better management of neonatal res-
piration, in terms of peak inspiration volume, intermit-
tent positive pressure ventilation and fraction of inhaled
Percentage of very low birth weight infants discharged on human milk in Trento area (2000–2005) and VON (2004) Figure 1
Percentage of very low birth weight infants discharged on human milk in Trento area (2000–2005) and VON 
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oxygen. These results are consistent with the multicentre
study by Bevilacqua et al, in which surfactant prophylaxis
was associated with a lower incidence of RDS compared
with rescue therapy [11]. It is noteworthy that VLBWI
receiving surfactant prophylaxis had a lower BW than
those treated with rescue therapy [11].
In Trento, the overall rates of PDA, NEC and IVH were
lower than in VON, occasionally reaching statistical sig-
nificance. As observed for respiratory complications, the
difference was greatest in the lowest BW groups. Overall,
these data are comparable with those reported in the Bev-
ilacqua study [11]. It may be that RDS is less common in
Trento area because of several factors: more prenatal ster-
oids; surfactant in delivery room; low amount of infused
liquids, thanks to the fact that in Trento the enteral feed-
ing with bank human milk and mother milk is preferred.
This management, mainly in the first week of life, gives as
a consequence high weight loss (about 20%), less PDA,
less RDS and less CLD, but also less indomethacin treat-
ment, less catheters and less antibiotics (with lower risk of
complications). In Trento it is usually used only one dose
of surfactant (in delivery room or in NICU) with extuba-
tion as soon as possible, also in delivery room. It is pre-
ferred NCPAP instead of mechanical ventilation when the
baby permits it.
Even the lower risk of NEC in Trento compared with VON
may be associated with specific therapeutic strategies of
the S. Chiara intensive care unit, such as the very early
administration of human milk (from the second hour
from birth, when possible). In fact, the percentage of dis-
charged infants receiving human milk was significantly
higher in Trento than in VON (83% vs. 44%, respec-
tively). Since 1993, the S. Chiara unit has employed the
early exclusive enteral feeding (EEEF) protocol that is
widely used in Scandinavian countries [14]. This protocol,
which is targeted to specific VLBWI conditions, is based
on the exclusive administration of human milk, either
from the mother or from a donor, to VLBWI weighing
750–1250 grams and with GA > 26 weeks. The EEEF pro-
tocol may be suitable for VLBWI undergoing CPAP, but
cannot be suggested for those treated with mechanical
ventilation or presenting with asphyxia, metabolic acido-
sis, hypotension, sepsis or persistent hypoglycaemia. Dur-
ing 2000–2005 in S. Chiara, the EEEF protocol was
initiated in 51.4% of VLBWI weighing 750–1250 grams
and with a GA > 26 weeks. Among these infants, only one
out of five (10.3% of the overall population) required fur-
ther nutritional support, while the majority (41.0% of the
total) did not.
Several studies have confirmed the importance of VLBWI
feeding with human milk. The high content of oligosac-
charides in human milk may improve the development of
immune system and prevent onset of NEC [15]. The
administration of human milk to VLBWI is recommended
by American Academy of Pediatrics and Canadian Pediatrics
Society because of its excellent energetic properties and for
its important effects on neural, cognitive and psychologi-
cal development [16,17]. In particular, feeding with
human milk is of great importance in VLBWI weighing
less than 1000 grams, because it is associated with signif-
icant improvements in survival and clinical outcomes
[18]. In Trento, significantly more VLBWI in both the
overall population (MH 139.7; p-value 0.00000) and in
BW sub-groups were discharged on human milk, com-
pared with VON.
Screening for ROP was about 2.5 times more common in
Trento than in VON. This strategy allows more rapid diag-
nosis of the potential presence of ROP. The frequency of
this condition (overall and severe grades) was lower in
Trento than in VON. An early diagnosis of ROP is of par-
ticular importance to prevent the risk of short- and long-
term damage to vision [19].
Mortality was comparable in the two populations,
although a trend towards lower mortality in Trento was
evident, especially in infants with BW ≤ 750 grams. It is
possible that the therapeutic strategies adopted in Trento,
such as surfactant prophylaxis and widespread use of
human milk, may be associated with a reduction in com-
plications and, as a consequence, with a lower mortality
in this high-risk class of VLBWI.
Conclusion
The comparison between VLBWI data collected during
2000–2005 in the S. Chiara intensive care unit of Trento
and those derived from the VON database shows that the
frequency of the most important complications associated
with intensive treatment was, in most cases, lower in the
Trento area. This difference may be due, at least in part, to
a greater use of prenatal steroids, to a less aggressive sur-
factant approach, based on prophylactic treatment instead
of rescue therapy, and greater feeding with human milk
using the EEEF protocol, which may be associated with
better development and lower incidence of NEC and
other complications. It is noteworthy that surfactant
prophylaxis is associated with reduced need for ventila-
tion assistance. Other factors, such as more extensive
screening for ROP, might contribute to decrease time and
cost associated with intensive care and to limit short- and
long-term consequences. These differences are particularly
evident in lower BW infants, which present a higher risk.
In conclusion, this study suggests that a less aggressive
therapeutic strategy, mostly based on prevention and on
global management, may be associated with an improve-
ment in clinical outcomes in preterm infants.Publish with BioMed Central    and   every 
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